Orange County is the stronger half of this industry in Southern California. Irvine, Tustin and the business parks around them hold a medical device cluster with few equals in the country, plus the contract manufacturers, sterilizers, molders and regulatory consultancies that serve it. Pay is high, equity is common, founders sit above the Roth limits, and candidates compare benefits line by line against employers ten minutes away.
Where do medical device, biotech and scientific R&D cluster in Orange County?
The centre of gravity is Irvine, and within Irvine it is two districts. The Irvine Business Complex around John Wayne Airport — the grid of Von Karman, MacArthur, Jamboree and Campus — carries the older device companies and a dense supplier base. The Irvine Spectrum and the research park adjacent to UC Irvine carry the newer end and the university-connected companies. Edwards Lifesciences and Masimo are headquartered in the city, and around anchors of that size sits a supplier and alumni economy: people who spent a decade at a large device firm and left to start something, and the vendors who learned to serve that customer.
The cluster spreads outward without thinning much. Tustin, including the Tustin Legacy redevelopment on the former Marine Corps air station, has absorbed a great deal of newer manufacturing and laboratory space. Costa Mesa, Santa Ana, Fountain Valley and Orange carry device manufacturing, diagnostics and the clinical side, with the university medical centre in Orange as a hospital anchor. Anaheim and Brea hold contract manufacturing and components. South of the roster on this page, Lake Forest and Aliso Viejo continue the same band down the 5 — the cluster does not stop at a page boundary.
What makes it a cluster rather than a collection is the supply chain. Injection molding and extrusion for medical polymers, precision machining, cleanroom assembly, contract sterilization, packaging validation, testing laboratories, regulatory and quality consultancies, and contract research organisations are all here, which means a company can go from concept to a submission without leaving the county. It also means an engineer, a quality manager or a regulatory specialist can change employers four times across a career and never change the commute. That is the fact your benefits package lives inside.
What does CalSavers require of a Orange County medical device, biotech and scientific R&D employer?
The same thing it requires everywhere in California, and every deadline has already passed. If you have one or more W-2 employees, you must either register with CalSavers or sponsor a qualified retirement plan and certify an exemption.
| Employees | Deadline | Where you stand in 2026 |
|---|---|---|
| 1–4 | 31 December 2025 | First notices are going out to this group now |
| 5–49 | 30 June 2022 | Confirm you are on file; watch for FTB notices |
| 50–99 | 30 June 2021 | Confirm, and revisit whether a 401(k) now fits better |
| 100+ | 30 September 2020 | Review plan design and fiduciary coverage |
Registration is free and the employer never touches the money. The exemption route is the one most medical device, biotech and scientific R&D miss: sponsoring your own plan does not exempt you automatically — you have to certify it, and the certification repeats.
What does ignoring it cost?
$250 per eligible employee at 90 days past notice, another $500 at 180 days, then $500 per employee every year you stay non-compliant (the full mechanics). For a 60-person operation that is $45,000 in the first cycle and $30,000 a year after — more than a plan would cost. If a notice has already landed, the 90-day FTB appeal window closes permanently at the final notice: read this before you file anything.
A notice already arrived?
Fifteen minutes on the phone and you will know exactly where you stand and what to do this week. No charge, no obligation, no product pitch.
What makes this industry harder than the mandate assumes?
The law treats every employer alike. The payroll underneath does not cooperate:
- A cheap startup 401(k) adopted at the first financing is still in place at sixty employees, with no fiduciary named in writing and no documented review.
- Equity compensation dominates every benefits discussion, so the qualified plan never gets the attention its actual cost and recruiting weight deserve.
- Headcount jumps at regulatory and commercial milestones, pushing the plan across testing and audit thresholds a year sooner than the forecast assumed.
- Founders and senior staff sit above the Roth income limits, so the state programme is unusable for exactly the people who most want to save.
- Candidates compare packages against dense competition within a short drive, and an unanswerable question about the plan costs a hire outright.
Typical headcount in this sector runs 10-250 employees, and roughly 60-75% of firms (est.) currently sponsor a plan of any kind — which is why the mandate lands here harder than in sectors that were already covered.
What plan design actually works?
Assume a safe harbor 401(k) as the base, because a company with founders, senior engineers and commercial leadership at the top of the pay scale will otherwise have their deferrals throttled by everyone else's participation rate. From there, the two design choices that matter most in this specific labor market are the Roth source and the employer contribution formula. The Roth source matters because a large share of an Orange County device payroll sits above the Roth IRA income limits and the plan is the only route left to Roth money at the $24,500 deferral limit. The formula matters because it is the number a candidate writes down.
We will not quote you a market match figure, because we cannot source one we would stand behind and an invented benchmark is worse than none. What we will do is model what a given formula costs against your actual census at your current headcount and at the headcount you are hiring toward, so the number you announce is one you can keep after the wave. Two more items belong on the list at sixty employees: name a 3(38) or 3(21) fiduciary in writing, because a company whose finance function is fractional has nobody performing the monitoring duty that ERISA assigns to somebody; and benchmark total plan cost including fund-level expenses, which for a plan placed at Series A is usually well above what a sixty-person plan can now obtain.
The SECURE 2.0 startup credits often cover most of the first three years of administration for employers under 50 staff — the formula, worked honestly. And if after the arithmetic CalSavers is genuinely the cheaper answer for your shop, we will tell you so and you can register and be done: the full comparison · run your own numbers.
| CalSavers | 401(k) | |
|---|---|---|
| Employee deferral limit (2026) | $7,500 | $24,500 |
| Employer match permitted | No — prohibited | Yes |
| Owner above the Roth income limits can participate | No | Yes |
| SECURE 2.0 startup credits | $0 | Up to $5,000/yr × 3 yrs |
| Named fiduciary available | No | Yes — 3(38) or 3(21) |
The Orange County wrinkle
Cluster density changes the economics of a benefits decision, and this is the county where that is most visible. When a quality engineer can take four interviews inside a fifteen-minute radius, your plan is being compared directly and repeatedly, by people who read documents carefully for a living. A candidate who has worked at a large device employer knows what a match formula looks like, knows what a vesting schedule means, and will ask what the plan's fees are — and a hiring manager who cannot answer has told them something. The other side of density is that the same effect works for you: you are recruiting from your neighbours as much as they are recruiting from you, and a specific, well-documented plan is a differentiator in a market where most companies say "competitive benefits" and stop.
The second Orange County pattern is the growth shape. Device companies here scale in steps tied to regulatory and commercial events rather than smoothly: a clearance or approval, a reimbursement decision, a first commercial launch, and the commercial and manufacturing headcount doubles inside two quarters. That is very hard on a plan built for the previous census. Nondiscrimination testing changes shape, entry dates arrive in batches, and the large-plan audit requirement — counted since the 2023 filing rules on participants with account balances rather than everyone eligible — can arrive a year earlier or later than expected depending on how enrollment was designed. This is worth modelling before the hiring wave rather than discovering at year-end.
Orange County has 34 incorporated cities and about 3.1 million residents, and the enforcement letters go out by employer, not by city — but which city you are in changes who your neighbours are, what your labor market looks like, and often what your local business tax and licensing burden already is. The city pages below go into that.
CalSavers compliance, city by city
Where medical device, biotech and scientific R&D concentrate in Orange County:
- CalSavers for Irvine employers
- CalSavers for Tustin employers
- CalSavers for Costa Mesa employers
- CalSavers for Santa Ana employers
- CalSavers for Orange employers
- CalSavers for Fountain Valley employers
- CalSavers for Newport Beach employers
- CalSavers for Anaheim employers
- CalSavers for Brea employers
All Orange County CalSavers guidance → · The medical device, biotech and scientific R&D plan guide, statewide → · The same industry in Los Angeles County →
Our fees, published
No competing advisor page in this area publishes its fees. Here are ours.
| What | Fee |
|---|---|
| Investment management | 1.5% to 2.0% of assets per year; Advisers may set a rate below the standard schedule, as low as 0%, at their discretion — and whatever rate applies to you is disclosed in writing before you engage. Our Form ADV Part 2A, Item 5, states the fee as up to 2.00% of assets per year, subject to negotiation; the firm may waive all or part of it. Generally billed quarterly in arrears |
| Account minimum | No minimum account balance |
| Commissions and product fees | None — we are fee-only |
| Solicitor compensation | May be received or paid under disclosed arrangements |
| Initial conversation | Free, 15 minutes, no obligation |
Complete fee details in our Form ADV Part 2A, Item 5.
Orange County medical device, biotech and scientific R&D questions
What match should a sixty-person device company in Irvine be offering?
We will not give you a market number, because we cannot cite a survey we are confident in for this specific county and sector, and a made-up benchmark would be worse than saying so. What is answerable is the cost side. Give us your census — ages, compensation, participation, and the hiring plan for the next eighteen months — and we will model what several formulas cost as a percentage of payroll now and after the hiring wave, including how a safe harbor design changes what your senior people can defer. Announce a number you can hold. Cutting a match later is far more damaging to recruiting than starting modestly.
We just got a clearance and are hiring forty people in two quarters. What should we do first?
Model the plan against the post-hire census before the first offer letter goes out. Three things move. Nondiscrimination testing changes as the ratio of highly compensated to other employees shifts, which a safe harbor design largely neutralises but only if adopted with proper notice and timing. Eligibility and entry dates arrive in a batch, so decide now whether new hires enter immediately or after a service period. And the large-plan audit requirement, counted on participants with account balances, may arrive sooner than expected — especially if you use automatic enrollment, which creates balances quickly. None of this is difficult in advance and all of it is unpleasant in arrears.
Our people came from the large device employers here. What are they expecting?
We are not going to characterise another company's plan and you should be sceptical of anyone who does. What is safe to say generally is that a large, established manufacturer typically runs a mature 401(k) with an employer contribution, an internal benefits function to explain it, and scale that produces low per-participant costs. A candidate coming from that environment is used to being able to get a straight answer about the match and the fees. The gap you can actually close is not the size of the match — it is the clarity. A one-page plan summary with the formula, the vesting schedule and the total cost stated plainly puts you ahead of most companies your size.
Our CFO is fractional and nobody really owns the plan. Does that matter?
Yes, and it is the most common failure at this size. ERISA assigns duties of selecting and monitoring investments and service providers to a plan fiduciary, and if nobody has been appointed in writing those duties sit with the company and, in practice, with whoever signs for it. "Our fractional CFO handles it" is not a fiduciary structure. The fix is administrative rather than expensive: appoint a fiduciary in writing — 3(38) discretionary or 3(21) advisory — adopt an investment policy statement, and hold and minute a review at a set interval. See how the fiduciary appointment works.
Do you actually work with medical device, biotech and scientific R&D in Orange County?
Yes. Our office is at 12838 Rosecrans Ave in Norwalk — inside Los Angeles County, and about a 30-minute drive from most of Orange County's business corridors. We meet at our office or at your place of business. Call (657) 571-2607. We are registered as an investment adviser in California.
¿Atienden en español?
Sí. Atendemos en español y nuestro material sobre CalSavers existe en español, escrito originalmente, no traducido por máquina.
A plan designed around medical device, biotech and scientific R&D in Orange County — not around the average employer
We design around the census you actually have — turnover, seasonality, owner compensation and all. Fifteen minutes, no charge, and a straight answer either way.